No Data
No Data
Health Care Stocks Show Relative Strength as S&P 500 Stalls
What's Going On With FibroGen Stock Tuesday?
FibroGen Inc (NASDAQ:FGEN) shares initially traded higher Tuesday morning after the company said the FDA cleared its Investigational New Drug (IND) of FG-3165. FibroGen also announced a new clinical t
Regeneron Pharma Is Maintained at Outperform by RBC Capital
Regeneron Pharma Is Maintained at Outperform by RBC Capital
Regeneron Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/04/2024 21.14% RBC Capital $1185 → $1200 Maintains Outperform 05/14/2024 16.09% Evercore ISI Group → $1
RBC Capital Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Raises Target Price to $1,200
RBC Capital analyst Brian Abrahams maintains $Regeneron Pharmaceuticals(REGN.US)$ with a buy rating, and adjusts the target price from $1,185 to $1,200.According to TipRanks data, the analyst has a su
U.S. stock market news: Coherent, a leading company in optical modules, rose nearly 23% overnight with the new CEO taking office. Cruise stocks also rallied, with Royal Caribbean's stock price reaching a historic high.
Better-than-expected performance! Costco, loved by Munger, has repeatedly set new highs after the results announcement, with a year-to-date increase of more than 23%, far outpacing the large cap.
No Data